- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Enterobacteriaceae in New Zealand
Total 8 results
-
Kaleido BiosciencesTerminatedVancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized SubjectsUnited States
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedE Coli InfectionUnited States
-
DynPort Vaccine Company LLC, A GDIT CompanyCompleted
-
Janssen Research & Development, LLCActive, not recruitingExtraintestinal Pathogenic Escherichia Coli PreventionUnited States, France, Belgium, Spain, Netherlands
-
LimmaTech Biologics AGGlaxoSmithKlineCompletedKlebsiella Pneumoniae InfectionGermany
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Worldwide Clinical TrialsTerminatedPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus SyndromeUnited States, Australia, Italy, Spain
-
Janssen Research & Development, LLCRecruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom